Trial Profile
Study on Uncontrolled Morning Surge for N-Type CCB and Low-Dose of HCTZ, Using the Internet-through Blood Pressure Data Transmission System
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Cilnidipine/valsartan (Primary) ; Valsartan/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms SUNLIGHT study
- 26 Jan 2021 Results (n=129) of post hoc analysis of the SUNLIGHT trial, published in the Journal of Clinical Hypertension (Greenwich)
- 04 Apr 2018 Status changed from active, no longer recruiting to completed.
- 23 Jan 2017 New trial record